May 12 (Reuters) - QBE Insurance Group Ltd (QBE) :
- GROWTH IN GROSS WRITTEN PREMIUM REMAINED STRONG IN 1Q23, UP 11% ON PCP
- GROUP-WIDE RENEWAL RATE INCREASES AVERAGED 10.0% IN 1Q23
- CATASTROPHE ACTIVITY HAS REMAINED ELEVATED THROUGH THE BEGINNING OF 2023
- TO APRIL, NET COST OF CATASTROPHE CLAIMS IS $480M, WHICH COMPARES TO QBE’S CATASTROPHE ALLOWANCE FOR 1H23 OF $535M
- 1Q23 EXIT CORE FIXED INCOME RUNNING YIELD IMPROVED TO 4.2% VERSUS FY22 EXIT RUNNING YIELD OF 4.1%
- AT 1Q23-END, TOTAL INVESTMENT FUNDS UNDER MANAGEMENT WAS $29.1 BILLION
- IN 2Q23 FUM WILL BE NEGATIVELY IMPACTED BY ABOUT $1.9 BILLION FROM RESERVE TRANSACTION ANNOUNCED IN FEB
- EXPECTS FY23 GROUP CONSTANT CURRENCY GWP GROWTH OF ABOUT 10%
- FY23 PLAN GROUP COMBINED OPERATING RATIO REVISED TO ABOUT 94.5%
- CURRENTLY ESTIMATES CROP GROSS WRITTEN PREMIUM WILL BE ABOUT $4.0 BILLION IN FY23, WITH NET EARNED PREMIUM OF ABOUT $1.4 BILLION
- Forums
- ASX - By Stock
- QBE
- News: QBE QBE Insurance Says Growth In Gross Written Premium Strong In 1Q23, Up 11% On PCP
QBE
qbe insurance group limited
Add to My Watchlist
1.07%
!
$21.66

News: QBE QBE Insurance Says Growth In Gross Written Premium Strong In 1Q23, Up 11% On PCP
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$21.66 |
Change
0.230(1.07%) |
Mkt cap ! $32.35B |
Open | High | Low | Value | Volume |
$21.85 | $21.85 | $21.49 | $17.54M | 811.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1023 | $21.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.67 | 474 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85 | 21.760 |
4 | 740 | 21.750 |
5 | 459 | 21.740 |
5 | 447 | 21.730 |
11 | 1515 | 21.720 |
Price($) | Vol. | No. |
---|---|---|
21.770 | 225 | 5 |
21.780 | 824 | 7 |
21.790 | 1369 | 10 |
21.800 | 1017 | 8 |
21.810 | 1173 | 7 |
Last trade - 10.18am 22/08/2025 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online